Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJGFK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and carries no set-aside designation. This award was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue delivery orders for a comprehensive portfolio of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its single-award IDC with the DLA under the SPE2DB program. The company's contract portfolio demonstrates consistent success in securing federal procurement opportunities for diverse pharmaceutical products, including oncology treatments, vaccines, biologics, and medical consumables distributed to military health facilities nationwide. This delivery order for Xtandi, an oncology medication, exemplifies the company's ongoing role in providing specialized pharmaceutical products to support the medical supply needs of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FJGFK?
SPE2DB25FJGFK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FJGFK worth?
The government has obligated $4,170 on SPE2DB25FJGFK.
Is contract SPE2DB25FJGFK an order under another contract?
Yes. SPE2DB25FJGFK is a delivery order under SPE2DB24D9224, an indefinite delivery contract.
Was contract SPE2DB25FJGFK competed?
The extent of competition for SPE2DB25FJGFK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award